CT衍生血流储备分数在急诊科中的临床应用
本研究在基于冠状动脉CT血管成像(CTA)的分诊方案中,评估了急性胸痛患者使用CT衍生血流储备分数(FFRCT)的可行性、安全性、临床结局和费用。结果显示,FFRCT可行,与单纯冠状动脉CTA相比,主要不良心脏事件和费用无差异;FFRCT阴性时推迟血运重建是安全的,且与侵入性血管造影中更高的非阻塞性疾病比例相关。
要点
- FFRCT阴性时推迟血运重建未发生死亡或心肌梗死。
- FFRCT阴性者侵入性血管造影显示非阻塞性疾病比例高于FFRCT阳性者和冠状动脉CTA组。
- FFRCT与单纯冠状动脉CTA的主要不良心脏事件和总费用无显著差异。
核心结论
- 在急性胸痛患者中,FFRCT可行,主要不良心脏事件和费用与单纯冠状动脉CTA无差异;FFRCT阴性时推迟血运重建是安全的,且与侵入性血管造影中更高的非阻塞性疾病比例相关。
研究设计与样本
- 研究纳入555例无已知冠状动脉疾病的急性胸痛患者,其中297例接受冠状动脉CTA和FFRCT(196例阴性,101例阳性),258例仅接受冠状动脉CTA;FFRCT≤0.80定义为血流动力学显著狭窄阳性;参考标准为侵入性冠状动脉造影。
诊断标准与关键数值
- FFRCT≤0.80视为血流动力学显著狭窄阳性;FFRCT排斥率为1.6%;90天主要不良心脏事件(包括死亡、非致死性心肌梗死和指数就诊后意外血运重建)在冠状动脉CTA组为4.3%,FFRCT组为2.7%(p=0.310);诊断失败(冠状动脉CTA或FFRCT结果与侵入性检查不一致)在两组分别为1.9%和1.68%(p=NS);FFRCT阴性者侵入性冠状动脉造影显示非阻塞性疾病的比例为56.5%,高于FFRCT阳性的8.0%和冠状动脉CTA的22.9%(p<0.001)。
临床应用与阅片要点
- 在急性胸痛分诊中,FFRCT阴性时推迟血运重建是安全的;FFRCT阴性者侵入性血管造影更常显示非阻塞性疾病。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study sought to examine the feasibility, safety, clinical outcomes, and costs associated with computed tomography-derived fractional flow reserve (FFRCT) in acute chest pain (ACP) patients in a coronary computed tomography angiography (CTA)-based triage program.
BACKGROUND: FFRCT is useful in determining lesion-specific ischemia in patients with stable ischemic heart disease, but its utility in ACP has not been studied.
METHODS: ACP patients with no known coronary artery disease undergoing coronary CTA and coronary CTA with FFRCT were studied. FFRCT ≤0.80 was considered positive for hemodynamically significant stenosis.
RESULTS: Among 555 patients, 297 underwent coronary CTA and FFRCT (196 negative, 101 positive), whereas 258 had coronary CTA only. The rejection rate for FFRCT was 1.6%. At 90 days, there was no difference in major adverse cardiac events (including death, nonfatal myocardial infarction, and unexpected revascularization after the index visit) between the coronary CTA and FFRCT groups (4.3% vs. 2.7%; p = 0.310). Diagnostic failure, defined as discordance between the coronary CTA or FFRCT results with invasive findings, did not differ between the groups (1.9% vs. 1.68%; p = NS). No deaths or myocardial infarction occurred with negative FFRCT when revascularization was deferred. Negative FFRCT was associated with higher nonobstructive disease on invasive coronary angiography (56.5%) than positive FFRCT (8.0%) and coronary CTA (22.9%) (p < 0.001). There was no difference in overall costs between the coronary CTA and FFRCT groups ($8,582 vs. $8,048; p = 0.550).
CONCLUSIONS: In ACP, FFRCT is feasible, with no difference in major adverse cardiac events and costs compared with coronary CTA alone. Deferral of revascularization is safe with negative FFRCT, which is associated with higher nonobstructive disease on invasive angiography.
引用
- Chinnaiyan KM, Safian RD, Gallagher ML, et al. Clinical Use of CT-Derived Fractional Flow Reserve in the Emergency Department. JACC Cardiovasc Imaging. 2019. PMID: 31326487. doi:10.1016/j.jcmg.2019.05.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。